Severe but Self-Limiting Polyarthralgia with Functional Impairment Following ChAdOx1 nCov-19 Vaccination in an Elderly Recipient

被引:3
作者
Chan, Joel Ern Zher [1 ,2 ,3 ]
Irimpen, Anand [1 ]
机构
[1] Investigator Clin, Port Lincoln, SA 5606, Australia
[2] Flinders & Upper North Local Hlth Network, Port Augusta, SA 5700, Australia
[3] Adelaide Med Sch, Adelaide, SA 5000, Australia
关键词
COVID-19; SARS-CoV-2; vaccine; Oxford/AstraZeneca; ChAdOx1; nCov-19; elderly patient; reactogenicity; adverse reactions; polyarthralgia; polymyalgia rheumatica; RHEUMATOID-ARTHRITIS; SARS-COV-2;
D O I
10.3390/vaccines9111220
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A 79-year-old female patient with no pre-existing rheumatological conditions presented with severe functional impairment secondary to polyarthralgia, most likely an adverse reaction following her first dose of Oxford/AstraZeneca ChAdOx1 nCov-19 vaccination against SARS-CoV-2, the causative agent of Coronavirus Disease 2019 (COVID-19). The presentation mimicked clinical features of polymyalgia rheumatica and was distinctive in its pattern and delayed onset. Its severity in an elderly patient was significant against trial findings of decreasing reactogenicity of ChAdOx1 nCov-19 vaccine with increasing age, and traumatic to the patient. Acute phase reactants were elevated, consistent with recent similar reports among mostly elderly, female patients. New onset rheumatological conditions and flares of pre-existing, well-controlled conditions had been well established in COVID-19 and, to a lesser extent, post-vaccination. Viral arthralgias as a distinct clinical entity in COVID-19 is only beginning to be recognized. It could be that this case report represents a similar entity which occurs following vaccination against SARS-CoV-2. Despite this, the benefits of vaccination continue to outweigh such risks, although this case report is important for providing understanding of clinical progression when such reactions occur, aiding in patient discussions and clinical decisions to weigh up further investigations or empirical treatment against reassurance and close monitoring.
引用
收藏
页数:5
相关论文
共 17 条
  • [1] Reactive arthritis after COVID-19 vaccination
    An, Qi-jun
    Qin, De-an
    Pei, Jin-xian
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (09) : 2954 - 2956
  • [2] Australian Technical Advisory Group on Immunisation, 2021, JOINT STAT ATAGI THA
  • [3] Recommencement of Sport Leagues With Spectators at the Adelaide Oval During the COVID-19 Pandemic: Planning, Experience, and Impact of a Globally Unprecedented Approach
    Chan, Joel Ern Zher
    Lee, Angela
    Lease, Chris
    Spurrier, Nicola
    [J]. FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [4] Autoimmune and inflammatory diseases following COVID-19
    Galeotti, Caroline
    Bayry, Jagadeesh
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (08) : 413 - 414
  • [5] Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms
    Hoong, Caroline Wei Shan
    Amin, Muhammad Nakib Monjur E.
    Tan, Teck Choon
    Lee, Jer En
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 104 : 363 - 369
  • [6] CHRONIC ARTHRITIS AFTER RUBELLA VACCINATION
    HOWSON, CP
    KATZ, M
    JOHNSTON, RB
    FINEBERG, HV
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 (02) : 307 - 312
  • [7] Polyarthralgia and Myalgia Syndrome after ChAdOx1 nCOV-19 Vaccination
    Hyun, Hakjun
    Song, Joon Young
    Seong, Hye
    Yoon, Jin Gu
    Noh, Ji Yun
    Cheong, Hee Jin
    Kim, Woo Joo
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (34)
  • [8] Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
    Kremer, Eric J.
    [J]. MOLECULAR THERAPY, 2020, 28 (11) : 2303 - 2304
  • [9] Whole-Genome Sequencing of SARS-CoV-2 from Quarantine Hotel Outbreak
    Leong, Lex E. X.
    Soubrier, Julien
    Turra, Mark
    Denehy, Emma
    Walters, Luke
    Kassahn, Karin
    Higgins, Geoff
    Dodd, Tom
    Hall, Robert
    D'Onise, Katina
    Spurrier, Nicola
    Bastian, Ivan
    Lim, Chuan K.
    [J]. EMERGING INFECTIOUS DISEASES, 2021, 27 (08) : 2219 - 2221
  • [10] Meena S., 2021, COMMUN DIS INTELL, V45, P1